CMS Releases Initial Guidance on the Medicare Drug Price Negotiation Program

On March 15, CMS released initial guidance describing the requirements and parameters on key elements of the new Medicare Drug Price Negotiation Program for 2026. The initial program guidance describes the requirements and procedures for the first set of negotiations, which will occur during 2023 and 2024 and result in prices effective in 2026.